Report: Cardinal Health top suitor for J&J's Cordis unit
February 23, 2015 by Brian Johnson
Healthcare giant Johnson & Johnson may have found a buyer for its Cordis business, according to Bloomberg News.
Cardinal Health has emerged as the leading suitor to buy Cordis, which makes stents, catheters and other vascular devices, according to the news service. Spokesman for J&J and Cardinal declined to comment on the rumor to Bloomberg. Anonymous sources told the Wall Street Journal in August that Cordis could command a $1.5 billion to $2 billion price tag. Read more
3M to buy Ivera Medical
February 19, 2015 by Val Kennedy
3M Cos. announced it has entered into an agreement to buy disinfectant-products maker Ivera.
Ivera’s lead product, the Curos I.V. port-connector cap, is used to help prevent catheter-related blood-stream infections, or CRBSIs. 3M said the product will complement its Tegaderm line of antimicrobial I.V. securement dressings. Read more
Allergan name to live on post Actavis merger
February 18, 2015 by Brian Johnson
Actavis will adopt the Allergan name once the $66 billion merger is complete, CEO Brent Saunders told CNBC this week.
“When you look at those two equities, both had lots of value, but Allergan really stood for innovation, it stood for customer focus, and that really describes I think the new company we are today better than Actavis,” Saunders said during an interview on the television show “Squawk Box.” Read more
Report: Lumenis in talks to be acquired by Fosun for $480M
February 19, 2015 by Brian Johnson
Lumenis Ltd., which raised nearly $100 million through an initial public offering on NASDAQ last year, is in talks to be acquired by Chinese conglomerate Fosun for nearly $500 million, according to the Israeli financial newspaper Calcalist.
The paper reported that Fosun officials had made initial contact with executives from Yokneam, Israel-based Lumenis, who indicated that they would accept an offer of $480 million for the company, a 26% premium over its current market value. Read more
Uroplasty, Vision-Sciences set date for merger vote
February 24, 2015 by Val Kennedy
Uroplasty and Vision-Sciences shareholders will vote on the proposed all-stock merger deal between the two companies on March 30, according to a regulatory filing.
Under the merger agreement, Uroplasty shareholders will receive 3.6331 shares of Vision-Sciences stock for each Uroplasty share. After the merger, Uroplasty shareholders will hold a 62.5% stake in the combined company, with Vision-Sciences shareholders holding the remaining 37.5%. Read more
From Medical Design & Outsourcing
- Qosina introduces RondelO stopcock manifoldsNEWS RELEASE: Qosina Introduces RondelO™ Stopcock Manifolds Ronkonkoma, NY, USA, September 21, 2023—Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, is pleased to introduce the RondelO™ stopcock manifold. The RondelO modernizes drug infusion protocols through an innovative, patented design. The RondelO is the world’s first medical stopcock manifold that… […]
- Superior Sensor expands CPAP pressure sensor familyNEWS RELEASE: Superior Sensor Technology Expands CPAP Pressure Sensor Family to Drive Better Patient Synchrony New CP Series Sensors Offer Faster System Response Time and New Safety Measures for PAP Devices, Providing a Higher Quality Patient Experience Los Gatos, CA, September 27, 2023 – Superior Sensor Technology today announced two new CP Series pressure sensors for Positive Airway Pressure (PAP)… […]
- CUI releases medical grade dc-dc converter with 2:1 input voltage and extended temperature rangeNEWS RELEASE: CUI Releases Medical Grade DC-DC Converter with 2:1 Input Voltage and Extended Temperature Range Tualatin, OR. [September 27, 2023] CUI Inc, a Bel group company, today announced the release of its PTP15 Series—a 15 W, 5 Pin DIP isolated dc-dc converter, specialized for medical instrumentation and home medical supplies. Offering 4000 Vac isolation… […]
- Surface Solutions Group introduces sustainable, compliant GlideMed medical device coatingNEWS RELEASE: Surface Solutions Group to Introduce Sustainable, Compliant GlideMed™ Medical Device Coating at MD&M Minneapolis CHICAGO, September 26, 2023 – ISO 13485 certified Surface Solutions Group, LLC (SSG), a leading provider of coating technologies for the medical device industry, today announced that it will be showcasing its GlideMed™ sustainable, compliant coating along with its… […]
- RWE tips from Boston Scientific Peripheral Interventions CMO Dr. Michael JaffReal-world evidence (RWE) is a transformational concept for medical device design and engineering, says Dr. Michael Jaff, the chief medical officer and VP of the Boston Scientific Peripheral Interventions business. “Every really great technological advancement in the vascular space has come from a physician’s recognition that they would like to be able to do something… […]
- Resonant Link and Cirtec partner on implantable medical devicesResonant Link and Cirtec Medical have entered into a strategic partnership to serve developers of implantable medical devices. The two medtech suppliers said today that the partnership will combine Resonant Link’s next-generation wireless power technology with Cirtec Medical’s product design, development and manufacturing expertise to “offer medical device makers the best technology, fully integrated components,… […]
- Johnson & Johnson MedTech plans manufacturing facility in Costa RicaJohnson & Johnson MedTech will build a 200,000-sf² manufacturing facility in Alajuela, Costa Rica, the medical device developer said today. It’s the largest investment J&J MedTech has ever made outside the U.S., according to Procomer, the agency that promotes Costa Rican exports. J&J MedTech — Johnson & Johnson’s medical device business, which by itself is… […]
- The secret behind Intuitive’s surgical robotics successIntuitive Surgical has pioneered robotic surgery since the 1990s, continuously driving innovation and collaboration through data to advance patient care. Teamwork between surgeons and engineers has been a crucial factor behind Intuitive developing effective surgical platforms that solve real-world problems that surgeons face. Multibillion-dollar companies including Medtronic and Johnson & Johnson — and smaller up-and-comers… […]
- 3D-printed ventricles made from fiber-infused gel ink mimic heartbeatsResearchers have found a way to use fiber-infused ink to 3D-print a functional heart ventricle that mimics the beating of a human heart. The team included researchers from Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and the Wyss Institute for Biologically Inspired Engineering at Harvard University. They reported on their new… […]
- Synchron’s plan to beat Neuralink in the neuroprosthetic BCI raceCompeting brain-computer interface (BCI) developers Synchron and Neuralink both announced big news this month as they move their dueling neuroimplant technologies forward. The device developers each have FDA investigational device exemption (IDE) for their experimental BCIs. They’ve also got billionaires backing their R&D and regulatory efforts, with Neuralink owned by Elon Musk and Synchron funded… […]
- How LimFlow’s foot-saving system prevents amputations in patients with no other optionsLimFlow’s breakthrough system for treating chronic limb-threatening ischemia (CLTI) is the first of its kind approved by the FDA for this severe form of peripheral artery disease (PAD). For CLTI patients who have lost blood flow below their knee and have no other suitable endovascular or surgical treatment options available, the LimFlow System for Transcatheter… […]
